This message contains images. If you don't see images, click here to view. Click
here to advertise in this news brief.
|

|
|
Looser guidelines issued on prostate screening
The New York Times
In a major shift, the American Urological Association has pulled back its strong support of prostate cancer screening, saying that the testing should be considered primarily by men aged 55 to 69.
|
|
Share this article:
    |
|
|
Advertisement
American Urological Association releases new prostate cancer screening guidelines
redOrbit
Healthy men under the age of 55 do not need routine annual prostate cancer screenings, according to new clinical practice guidelines released by the American Urological Association. The agency, which USA Today reporter Liz Szabo said "staunchly defended" prostate-specific antigen screenings in recent years, has now declared the tests are "not recommended" for anyone under the age of 40, for average-risk men between the ages of 40 and 54, and for anyone over age 70 or with a remaining life expectancy of between 10 and 15 years, the organization noted.
Doctors to older, heavy smokers: Get CT screening for lung cancer
Reuters
Stepping into the debate over who should be screened for lung cancer, a leading medical specialty group issued new guidelines recommending that doctors offer annual low-dose computed tomography scanning to people whose age and smoking history puts them at significant risk of lung cancer.
PRODUCT SHOWCASE
Certain bladder-cancer patients may be at high risk of disease recurrence despite bladder removal
Medical Xpress
The five-year international study led by researchers at UT Southwestern validates the use of a marker panel to predict which patients are more likely to have a recurrence of cancer after bladder removal, thereby identifying those patients as good candidates for follow-up chemotherapy.
Screening for ovarian cancer
American Academy of Physician Assistants
The American Cancer Society projects that in 2013, ovarian cancer will be diagnosed in an estimated 22,240 women and about 14,300 women will die from the disease. Ovarian cancer is the ninth most common cancer among women and fifth in cancer deaths.
Looking for similar articles? Search here, keyword OVARIAN. |
|
Hundreds of possible ways to starve cancer
Columbia University via Futurity.org
An analysis of gene expression from 22 types of tumors has come up with hundreds of potential drug targets that could cut off cancer's fuel supply. Scientists say the results should ramp up research into drugs that interfere with cancer metabolism, a field that dominated cancer research in the early 20th century and has recently undergone a renaissance.
|
FEATURED COMPANIES
Oncology OnTrack is used to navigate patients with any cancer type from screening to diagnosis, treatment and survivorship, interfaces with other programs and supports accreditations.
|
|
To find out how to feature your company in The CoC Brief and other advertising opportunities, contact James DeBois at 469-420-2618.
MORE
|
|
FDA urges steps to prevent breast cancer drug mix-ups
AHA News
To reduce the potential for medication errors, healthcare professionals should include the FDA-approved nonproprietary name when ordering the breast cancer drug Kadcyla, the Food and Drug Administration announced.
Low-risk skin cancers often treated too aggressively in elderly
The New York Times
The patient who made Dr. Eleni Linos wonder about the way we treat small, nonthreatening skin cancers in the elderly was 95 years old. "He was truly suffering," recalled Linos, a dermatologist at the University of California, San Francisco.
National Cancer Survivors Day® free poster
Commission on Cancer
The CoC encourages your CoC-accredited program to organize an event in honor of National Cancer Survivors Day®. Sponsored by Coping, this day is always the first Sunday in June and was established to bring cancer survivors together showing that there is life after receiving a diagnosis of cancer.
Video game gives young patients a fun way to battle their serious diseases
New York Daily News
The video games, developed by nonprofit HopeLab, help teens and adolescents understand their cancers better and inspire them to take charge of their own health, experts say.
Register today for Survey Savvy
Commission on Cancer
Registration is open for the 2013 Commission on Cancer's workshop Survey Savvy: Enhance Quality — Commit to Patient Centered Care, June 27-28 in Chicago. Take advantage of this opportunity to attend the optional preconference workshop "Leverage the Rapid Quality Reporting System to Improve Quality Performance and Deliver Evidence-Based Cancer Care" from 1-5 p.m. June 26. Space is limited, so register today!
Statins tied to better prostate cancer outcomes
The New York Times
A new study suggests that men with prostate cancer who take statins may have a lower risk of dying from the disease than those who do not. Statins are not recommended for prostate cancer prevention or treatment. But researchers studied 1,001 prostate cancer patients diagnosed between 2002 and 2005, of whom 289 used statins, which are given mainly to lower cholesterol.
Survey Savvy preconference: Setting up for Success: Implementation and Best Practices for the Rapid Quality Reporting System
Commission on Cancer
Do you know what the Rapid Quality Reporting System is? Are you a new RQRS participant learning the ropes? Is your cancer program considering enrolling in this important system?
Make sure that know how to take full advantage of the information available to CoC accredited programs by attending this valuable half-day preconference in Chicago June 26! Hear how three current RQRS programs have integrated RQRS into their CoC-accredited programs. CoC staff will explain how to navigate and use the system for quality improvement. Register today while space is still available.
|
|
|
|
|
|
The CoC Brief
Colby Horton, Vice President of Publishing, 469.420.2601 Download media kit
Andrew Plock, Content Editor, 469.420.2609 Contribute news
Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.
Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.
This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
|
|
Recent issues
May 1, 2013
April 24, 2013
April 17, 2013
April 10, 2013
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|